Telemedicine increases access to care for assisted living residents with dementia: study
By
Kimberly Bonvissuto
May 30, 2023
Although racial/ethnic and socioeconomically disadvantaged populations were less likely to use telemedicine early in the COVID-19 pandemic, a new study finds that telemedicine offered a way for members...
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
Behavioral health-memory care model serves increasing needs in senior living
By
Kimberly Bonvissuto
Aug 16, 2023
Cascade Senior Living Servicesgot creative by pursuing uncommon contracts and specialty partnerships to serve people living with significant mental health or dementia diagnoses.
Master Plan for Aging adds dementia screening tool for providers
By
Lois A. Bowers
Apr 17, 2023
Primary care providers in the country’s most populous state have a new screening tool to help them identify cognitive decline in older adults and determine next steps.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
Industry advocates join coalition to support federal bill requiring use of Alzheimer’s detection tools
By
Kimberly Bonvissuto
Oct 04, 2023
A bipartisan bill requiring the use of cognitive impairment detection tools in the early detection of Alzheimer’s disease and related dementias has the support of the senior living industry.
Study maps ‘home time’ for Medicare beneficiaries in assisted living communities
By
Kristen Fischer
Dec 21, 2023
A new study gives more insight into how much time older people in assisted living spend in and out of the setting.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.